BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18511033)

  • 1. Synergy between a NR2B receptor antagonist DHQ and 3-methyl-gabapentin in mice with neuropathic pain.
    Imai A; Hizue M; Toide K
    Eur J Pharmacol; 2008 Jul; 588(2-3):244-7. PubMed ID: 18511033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain.
    Field MJ; Gonzalez MI; Tallarida RJ; Singh L
    J Pharmacol Exp Ther; 2002 Nov; 303(2):730-5. PubMed ID: 12388658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
    Kawai M; Ando K; Matsumoto Y; Sakurada I; Hirota M; Nakamura H; Ohta A; Sudo M; Hattori K; Takashima T; Hizue M; Watanabe S; Fujita I; Mizutani M; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5558-62. PubMed ID: 17766106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifenprodil induced antinociception and decreased the expression of NR2B subunits in the dorsal horn after chronic dorsal root ganglia compression in rats.
    Zhang W; Shi CX; Gu XP; Ma ZL; Zhu W
    Anesth Analg; 2009 Mar; 108(3):1015-20. PubMed ID: 19224818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state characterization of an NR2B selective N-methyl d-aspartate (NMDA) antagonist polymorphs.
    Kojima T; Sato M; Omura A; Kawai M; Sakai M; Matsuoka Y; Murata Y; Hattori K; Sakemi S; Bordner J; Samardjiev I; Mano T
    Int J Pharm; 2008 May; 355(1-2):337-40. PubMed ID: 18242021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist.
    Suetake-Koga S; Shimazaki T; Takamori K; Chaki S; Kanuma K; Sekiguchi Y; Suzuki T; Kikuchi T; Matsui Y; Honda T
    Pharmacol Biochem Behav; 2006 May; 84(1):134-41. PubMed ID: 16764916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
    Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons.
    Noh J; Lee ES; Chung JM
    J Neurochem; 2009 Jun; 109(5):1261-71. PubMed ID: 19302475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
    Hashimoto K
    J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
    [No Abstract]   [Full Text] [Related]  

  • 13. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
    Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
    Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity.
    Valsecchi AE; Franchi S; Panerai AE; Sacerdote P; Trovato AE; Colleoni M
    J Neurochem; 2008 Oct; 107(1):230-40. PubMed ID: 18691380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of harmaline-induced tremor activity in mice.
    Paterson NE; Malekiani SA; Foreman MM; Olivier B; Hanania T
    Eur J Pharmacol; 2009 Aug; 616(1-3):73-80. PubMed ID: 19497322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bed nucleus of the stria terminalis N-methyl-D-aspartate receptors and nitric oxide modulate the baroreflex cardiac component in unanesthetized rats.
    Alves FH; Crestani CC; Resstel LB; Correa FM
    J Neurosci Res; 2009 May; 87(7):1703-11. PubMed ID: 19156861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
    Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
    Mares P; Mikulecká A
    Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.